This is an archived document. The links are no longer being updated.
1998 Surveillance Slides
MDR TB Cases
United States, 1993 - 1998
|Slide 18: MDR TB Cases, 1993-1998.
During 1993 through 1998, 45 states and the District of Columbia
reported at least one multidrug-resistant TB (MDR TB) case
(i.e., resistance to at least isoniazid and rifampin, the
two most important anti-TB drugs). MDR TB requires the use
of second-line anti-TB drugs and a prolonged duration of therapy.
Physicians with clinical expertise in the management of MDR
TB should always be involved in the care of these patients.
Contact investigations around MDR TB cases also require clinical
experts to assist in management of infected contacts. All
health departments must be prepared to meet the challenge
of MDR TB.
Released October 2008
Centers for Disease Control and Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Division of Tuberculosis Elimination - http://www.cdc.gov/tb
Please send comments/suggestions/requests
CDC/Division of Tuberculosis Elimination
Communications, Education, and Behavioral Studies Branch
1600 Clifton Rd., NE - Mailstop E-10, Atlanta, GA 30333